X. Wang

ORCID: 0009-0002-9883-0012
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Biomedical Text Mining and Ontologies
  • Machine Learning in Healthcare
  • Topic Modeling
  • Web Data Mining and Analysis
  • Recommender Systems and Techniques
  • Chronic Lymphocytic Leukemia Research
  • Statistical Methods in Clinical Trials
  • Biosimilars and Bioanalytical Methods
  • Electronic Health Records Systems
  • Genomics and Rare Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Radiomics and Machine Learning in Medical Imaging

Sema4 (United States)
2022-2024

Renmin University of China
2024

10.1145/3626772.3657963 article EN Proceedings of the 45th International ACM SIGIR Conference on Research and Development in Information Retrieval 2024-07-10

Due to the advantages in cost-efficiency and reproducibility, user simulation has become a promising solution user-centric evaluation of information retrieval systems. Nonetheless, accurately simulating search behaviors long been challenge, because users' actions are highly complex driven by intricate cognitive processes such as learning, reasoning, planning. Recently, Large Language Models (LLMs) have demonstrated remarked potential human-level intelligence used building autonomous agents...

10.48550/arxiv.2403.09142 preprint EN arXiv (Cornell University) 2024-03-14

Abstract The use of electronic health records (EHRs) holds the potential to enhance clinical trial activities. However, identification eligible patients within EHRs presents considerable challenges. We aimed develop a pipeline for phenotyping eligibility criteria, enabling from with characteristics that match those criteria. utilized criteria and patient Mount Sinai Database. EHR data were normalized using national standard terminologies in-house databases, facilitating computability...

10.1101/2024.02.28.24303396 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-03-02

The use of electronic health records (EHRs) holds the potential to enhance clinical trial activities. However, identification eligible patients within EHRs presents considerable challenges. We aimed develop a CriteriaMapper system for phenotyping eligibility criteria, enabling from with characteristics that match those criteria. utilized criteria and patient Mount Sinai Database. was developed normalize using national standard terminologies in-house databases, facilitating computability...

10.1038/s41598-024-77447-x article EN cc-by-nc-nd Scientific Reports 2024-10-25

<title>Abstract</title> The use of electronic health records (EHRs) holds the potential to enhance clinical trial activities. However, identification eligible patients within EHRs presents considerable challenges. We aimed develop a pipeline for phenotyping eligibility criteria, enabling from with characteristics that match those criteria. utilized criteria and patient Mount Sinai Database. EHR data were normalized using national standard terminologies in-house databases, facilitating...

10.21203/rs.3.rs-4215167/v1 preprint EN cc-by Research Square (Research Square) 2024-04-22

Background The European League Against Rheumatism (EULAR) 1 recently provided updated guidelines regarding the initiation and modification of disease-modifying antirheumatic drug (DMARD) therapy in patients with Rheumatoid Arthritis (RA). Therefore, real-world evidence studies are warranted to provide insights into first-line DMARD utilization durability response second-line setting. Objectives To analyze RA treatment patterns data compare between DMARDs + anti-TNF (TNFi) therapies vs. TNFi...

10.1136/annrheumdis-2022-eular.4655 article EN Annals of the Rheumatic Diseases 2022-05-23
Coming Soon ...